Published in Front Physiol on October 28, 2016
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet (2004) 42.12
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med (2015) 16.87
Analysis of protein-coding genetic variation in 60,706 humans. Nature (2016) 11.83
Reconstructing Indian population history. Nature (2009) 9.28
Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE) Lancet (2000) 8.01
The Human Gene Mutation Database: building a comprehensive mutation repository for clinical and molecular genetics, diagnostic testing and personalized genomic medicine. Hum Genet (2014) 6.69
Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J (2007) 6.34
A molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation. Cell (1990) 5.77
The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms. Cell (2001) 5.35
Haplotype-resolved genome sequencing of a Gujarati Indian individual. Nat Biotechnol (2010) 5.32
ACMG clinical laboratory standards for next-generation sequencing. Genet Med (2013) 5.30
Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. N Engl J Med (2003) 5.17
Going east: new genetic and archaeological perspectives on the modern human colonization of Eurasia. Science (2006) 4.97
Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere. Cell (1994) 4.47
Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome. Nature (2010) 4.38
Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction. Circulation (2006) 3.82
Prevalence of Anderson-Fabry disease in male patients with late onset hypertrophic cardiomyopathy. Circulation (2002) 3.22
Prevention of muscular dystrophy in mice by CRISPR/Cas9-mediated editing of germline DNA. Science (2014) 2.93
The genetic heritage of the earliest settlers persists both in Indian tribal and caste populations. Am J Hum Genet (2003) 2.82
Hypertrophic cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine. J Am Coll Cardiol (2014) 2.75
A common MYBPC3 (cardiac myosin binding protein C) variant associated with cardiomyopathies in South Asia. Nat Genet (2009) 2.67
Health characteristics of the Asian adult population: United States, 2004-2006. Adv Data (2008) 2.64
Morphology and significance of the left ventricular collagen network in young patients with hypertrophic cardiomyopathy and sudden cardiac death. J Am Coll Cardiol (2000) 2.33
Abnormal calcium handling properties underlie familial hypertrophic cardiomyopathy pathology in patient-specific induced pluripotent stem cells. Cell Stem Cell (2013) 2.33
Study familial hypertrophic cardiomyopathy using patient-specific induced pluripotent stem cells. Cardiovasc Res (2014) 2.25
Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy. Nat Genet (1997) 2.20
Report of a National Heart, Lung, And Blood Institute Workshop: heterogeneity in cardiometabolic risk in Asian Americans In the U.S. Opportunities for research. J Am Coll Cardiol (2010) 2.15
A Tension-Based Model Distinguishes Hypertrophic versus Dilated Cardiomyopathy. Cell (2016) 2.15
Myofilament Ca2+ sensitization causes susceptibility to cardiac arrhythmia in mice. J Clin Invest (2008) 2.02
Population-based variation in cardiomyopathy genes. Circ Cardiovasc Genet (2012) 2.00
Ethnic differences in cardiovascular disease. Heart (2003) 1.96
Hypertrophic cardiomyopathy: a review. Anesth Analg (2015) 1.78
Myofilament calcium sensitivity and cardiac disease: insights from troponin I isoforms and mutants. Circ Res (2002) 1.77
Sarcomeric proteins and inherited cardiomyopathies. Cardiovasc Res (2007) 1.75
South Asians and cardiovascular risk: what clinicians should know. Circulation (2006) 1.74
Ancestry and disease in the age of genomic medicine. N Engl J Med (2010) 1.71
Call to action: cardiovascular disease in Asian Americans: a science advisory from the American Heart Association. Circulation (2010) 1.69
Understanding cardiomyopathy phenotypes based on the functional impact of mutations in the myosin motor. Circ Res (2012) 1.69
Uncoupling of myofilament Ca2+ sensitivity from troponin I phosphorylation by mutations can be reversed by epigallocatechin-3-gallate. Cardiovasc Res (2015) 1.63
Diltiazem treatment for pre-clinical hypertrophic cardiomyopathy sarcomere mutation carriers: a pilot randomized trial to modify disease expression. JACC Heart Fail (2014) 1.58
Mechanisms of disease: hypertrophic cardiomyopathy. Nat Rev Cardiol (2011) 1.55
Hypertrophic Cardiomyopathy in Adulthood Associated With Low Cardiovascular Mortality With Contemporary Management Strategies. J Am Coll Cardiol (2015) 1.55
Mediators of Atherosclerosis in South Asians Living in America (MASALA) study: objectives, methods, and cohort description. Clin Cardiol (2013) 1.53
Mutation analysis of the main hypertrophic cardiomyopathy genes using multiplex amplification and semiconductor next-generation sequencing. Circ J (2014) 1.50
Modifier genes for hypertrophic cardiomyopathy. Curr Opin Cardiol (2002) 1.47
Hypertrophic and dilated cardiomyopathy: four decades of basic research on muscle lead to potential therapeutic approaches to these devastating genetic diseases. Biophys J (2014) 1.44
Increase in tension-dependent ATP consumption induced by cardiac troponin T mutation. Am J Physiol Heart Circ Physiol (2005) 1.41
Cardiac manifestations of primary mitochondrial disorders. Int J Cardiol (2014) 1.37
Functional analyses of troponin T mutations that cause hypertrophic cardiomyopathy: insights into disease pathogenesis and troponin function. Proc Natl Acad Sci U S A (1998) 1.29
Disease pathways and novel therapeutic targets in hypertrophic cardiomyopathy. Circ Res (2011) 1.28
Spectrum of cardiovascular diseases inAsian-American racial/ethnic subgroups. Ann Epidemiol (2011) 1.27
Genetic complexity in hypertrophic cardiomyopathy revealed by high-throughput sequencing. J Med Genet (2013) 1.27
2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2011) 1.27
Diabetes and cardiovascular disease among Asian Indians in the United States. J Gen Intern Med (2005) 1.24
The human genetic history of South Asia. Curr Biol (2010) 1.24
Human Pompe disease-induced pluripotent stem cells for pathogenesis modeling, drug testing and disease marker identification. Hum Mol Genet (2011) 1.23
Chromatin remodeling in the noncoding repeat expansion diseases. J Biol Chem (2008) 1.22
Direct cardiac reprogramming: progress and challenges in basic biology and clinical applications. Circ Res (2015) 1.16
A small-molecule inhibitor of sarcomere contractility suppresses hypertrophic cardiomyopathy in mice. Science (2016) 1.11
A common MLP (muscle LIM protein) variant is associated with cardiomyopathy. Circ Res (2009) 1.11
Increased myofilament Ca2+-sensitivity and arrhythmia susceptibility. J Mol Cell Cardiol (2010) 1.11
Cardiac structural and sarcomere genes associated with cardiomyopathy exhibit marked intolerance of genetic variation. Circ Cardiovasc Genet (2012) 1.10
A systematic review and meta-analysis of genotype-phenotype associations in patients with hypertrophic cardiomyopathy caused by sarcomeric protein mutations. Heart (2013) 1.08
Pompe disease: from pathophysiology to therapy and back again. Front Aging Neurosci (2014) 1.06
Novel deletions in MYH7 and MYBPC3 identified in Indian families with familial hypertrophic cardiomyopathy. J Mol Cell Cardiol (2003) 1.04
Microvascular function is selectively impaired in patients with hypertrophic cardiomyopathy and sarcomere myofilament gene mutations. J Am Coll Cardiol (2011) 1.03
Cardiomyopathy in congenital and acquired generalized lipodystrophy: a clinical assessment. Medicine (Baltimore) (2010) 1.03
Comparison of the functional significance of left ventricular hypertrophy in hypertrophic cardiomyopathy and glycogenosis type III. Am J Cardiol (1997) 1.02
Cardiac myosin-binding protein C in hypertrophic cardiomyopathy: mechanisms and therapeutic opportunities. J Mol Cell Cardiol (2011) 1.01
Detailed analysis of gene polymorphisms associated with ischemic stroke in South Asians. PLoS One (2013) 1.00
Deletion mutation in BSCL2 gene underlies congenital generalized lipodystrophy in a Pakistani family. Diagn Pathol (2013) 0.94
Endothelin-1 induces myofibrillar disarray and contractile vector variability in hypertrophic cardiomyopathy-induced pluripotent stem cell-derived cardiomyocytes. J Am Heart Assoc (2014) 0.94
Genetics of hypertrophic cardiomyopathy: advances and pitfalls in molecular diagnosis and therapy. Appl Clin Genet (2014) 0.94
Glycogenosis type II: protein and DNA analysis in five South African families from various ethnic origins. Am J Hum Genet (1989) 0.94
Distinguishing hypertrophic cardiomyopathy-associated mutations from background genetic noise. J Cardiovasc Transl Res (2014) 0.93
The genetic landscape of cardiomyopathy and its role in heart failure. Cell Metab (2015) 0.92
Sequencing and analysis of a South Asian-Indian personal genome. BMC Genomics (2012) 0.91
Multidimensional structure-function relationships in human β-cardiac myosin from population-scale genetic variation. Proc Natl Acad Sci U S A (2016) 0.90
The R403Q myosin mutation implicated in familial hypertrophic cardiomyopathy causes disorder at the actomyosin interface. PLoS One (2007) 0.90
Molecular characterisation of GSD III subjects and identification of six novel mutations in AGL. Hum Mutat (2002) 0.89
The role of renin-angiotensin-aldosterone system polymorphisms in phenotypic expression of MYBPC3-related hypertrophic cardiomyopathy. Eur J Hum Genet (2012) 0.87
MYBPC3 gene variations in hypertrophic cardiomyopathy patients in India. Can J Cardiol (2008) 0.87
Genome editing in cardiovascular diseases. Nat Rev Cardiol (2016) 0.86
MYBPC3's alternate ending: consequences and therapeutic implications of a highly prevalent 25 bp deletion mutation. Pflugers Arch (2013) 0.85
Determining pathogenicity of genetic variants in hypertrophic cardiomyopathy: importance of periodic reassessment. Genet Med (2013) 0.85
Contractility parameters of human β-cardiac myosin with the hypertrophic cardiomyopathy mutation R403Q show loss of motor function. Sci Adv (2015) 0.85
Principal component analysis reveals the 1000 Genomes Project does not sufficiently cover the human genetic diversity in Asia. Front Genet (2013) 0.84
Association of 25 bp deletion in MYBPC3 gene with left ventricle dysfunction in coronary artery disease patients. PLoS One (2011) 0.84
Worse prognosis with gene mutations of beta-myosin heavy chain than myosin-binding protein C in Chinese patients with hypertrophic cardiomyopathy. Clin Cardiol (2008) 0.84
Impact of heart disease and quality of care on minority populations in the United States. J Natl Med Assoc (2006) 0.84
Cardiovascular Disease in South Asian Migrants. Can J Cardiol (2015) 0.83
Coexistence of Digenic Mutations in Both Thin (TPM1) and Thick (MYH7) Filaments of Sarcomeric Genes Leads to Severe Hypertrophic Cardiomyopathy in a South Indian FHCM. DNA Cell Biol (2015) 0.83
Noninvasive cardiac imaging in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol (2006) 0.83
Computational approaches to interpreting genomic sequence variation. Genome Med (2014) 0.82
ACE I/D polymorphism in Indian patients with hypertrophic cardiomyopathy and dilated cardiomyopathy. Mol Cell Biochem (2007) 0.82
Cardiomyopathy in a dish: using human inducible pluripotent stem cells to model inherited cardiomyopathies. J Card Fail (2015) 0.82
Genotype phenotype correlations of cardiac beta-myosin heavy chain mutations in Indian patients with hypertrophic and dilated cardiomyopathy. Mol Cell Biochem (2008) 0.82
Mechanistic heterogeneity in contractile properties of α-tropomyosin (TPM1) mutants associated with inherited cardiomyopathies. J Biol Chem (2014) 0.81
Genetic basis and pathogenesis of familial WPW syndrome. Indian Pacing Electrophysiol J (2003) 0.81
The South Asian genome. PLoS One (2014) 0.81